GlassScriptPhysician profile
John T Growney
NPI 1902871353
$1,254.25
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $96.76 · 2020: $172 · 2021: $497 · 2022: $445 · 2023: $43.61.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $43.61.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $43.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Indivior INC. | $276.13 | 2019-2022 | |
| Abbvie INC. | $190.36 | 2021-2023 | |
| Lilly USA, LLC | $169.17 | 2020-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $129.53 | 2021-2022 | |
| Novo Nordisk INC | $106.06 | 2020-2023 | Rybelsus, Ozempic |
| E.R. Squibb & Sons, L.L.C. | $93.74 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $82.11 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $51.13 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $32.14 | 2020 | |
| Organogenesis INC. | $31.10 | 2021 | |
| Nestle Healthcare Nutrition INC. | $22.18 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $14.55 | 2022 | |
| Genentech USA, INC. | $14.42 | 2021 | |
| Allergan, INC. | $14.29 | 2020 | |
| Esperion Therapeutics, INC. | $14.14 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $13.20 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Growney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.